ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results · H2 FY26

Medicamen Organics H2 FY26 Results: Net Loss of ₹6.1 Cr

Medicamen Organics Ltd reported revenue from operations of ₹4.8 Cr (-77.8% YoY) and a net loss of ₹6.1 Cr for H2 FY26.

H2 FY26 at a glance · ₹ crore
MetricH2 FY26H1 FY26H2 FY25
Revenue from operations4.817.921.6
Other income0.00.10.1
Total income4.817.921.6
Profit before exceptional items & tax-8.02.73.2
Profit before tax-8.02.73.2
Net profit-6.12.02.5
Operating margin-166.7%15.1%14.8%

A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.

Growth
Revenue, year on year-77.80%
Source

NSE results filing, NSE: MEDIORG. Figures extracted from the filing.

Read the filing ↗

Medicamen Organics Ltd: key numbers

Share price
₹24.65
Market cap
₹36.68 Cr
Revenue (annual)
₹22.63 Cr
Net profit (annual)
₹-4.02 Cr
P/E (TTM)
-9.1×Sector 43.8×
Promoter holding
54.89%
FII holding
0.05%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Medicamen Organics Ltd

All →